Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (£272m) over five years due to Washington's demand for confidential information.
This move was revealed following a government memo from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesperson later stated that the US was demanding access to biological samples for research and commercial gain but was unwilling to share the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for continued talks to secure a agreement suitable to all parties so the country's vital HIV programme can be sustained.
Broader Implications
This rejection follows a comparable situation in Kenya, where a court halted a similar health funding agreement following legal challenges were filed about the security of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and accountability.
As per statements, 16 nations in Africa have so far agreed to these new agreements, representing more than $18.3bn in committed funds.
Details of the Rejected Deal
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no equivalent guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that shared data," he stated.
"Effectively, our nation would provide the basic resources for scientific discovery without any certainty that the final treatments would be available to our population should a new disease outbreak emerge."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were disrupting systems already set up through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.
"This mechanism is designed to guarantee that when a nation contributes its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
The government's concerns over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We encourage further dialogue with our American counterparts on how subsequent co-operation could be designed in a manner that respects the sovereignty and dignity of both nations."
Health Experts Response
A leading public health body said it recognised the official position, but suggested that negotiations need to persist considering much of the nation's HIV programmes relied on foreign aid.
"In cases where technical issues arise, including those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," it added.
This impasse underscores the continuing debate between accepting vital foreign assistance and protecting a country's data in an increasingly interconnected world.